Persoon-Rothert M, van der Valk-Kokshoorn E J, Egas-Kenniphaas J M, Mauve I, van der Laarse A
Department of Cardiology, University Hospital, Leiden, The Netherlands.
J Mol Cell Cardiol. 1989 Dec;21(12):1285-91. doi: 10.1016/0022-2828(89)90674-3.
The cardiotoxic effect of the beta-adrenergic agonist isoproterenol was studied in cultured neonatal rat myocytes. A progressive increase in irreversible cell injury as determined by leakage of the cytoplasmic enzyme alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) from the cells was noted at concentrations above 2.5 x 10(-4) M isoproterenol (exposure time 6 h). The isoproterenol-induced cell damage was reduced or prevented by several free radical scavengers: the application of Trolox C, a water-soluble vitamin E analogue, ICRF-159, a chelator of divalent cations, ascorbic acid, a potent antioxidant, as well as the enzymatic free radical scavengers superoxide dismutase and catalase reduced alpha-HBDH release. This study corroborates the hypothesis that oxidation products of isoproterenol, especially the formation of oxygen- and/or oxygen-derived free radicals, are responsible for the cytotoxicity observed after prolonged exposure to isoproterenol. In contrast to isoproterenol, exposure to 5 x 10(-4) M fenoterol, another beta-adrenergic agonist which is not oxidized, does not impair the viability of the myocytes. Moreover, application of the beta-blocker propranolol (10(-4) M, 10(-5)M) in combination with 5 x 10(-4) M isoproterenol does not prevent alpha-HBDH release. These findings suggest that isoproterenol-induced cardiotoxicity is not the result of excessive beta-adrenoceptor activation, but is mediated by the formation of free radicals.
在培养的新生大鼠心肌细胞中研究了β-肾上腺素能激动剂异丙肾上腺素的心脏毒性作用。当异丙肾上腺素浓度高于2.5×10⁻⁴M(暴露时间6小时)时,可观察到细胞质酶α-羟丁酸脱氢酶(α-HBDH)从细胞中泄漏所确定的不可逆细胞损伤逐渐增加。几种自由基清除剂可减少或预防异丙肾上腺素诱导的细胞损伤:应用水溶性维生素E类似物Trolox C、二价阳离子螯合剂ICRF-159、强效抗氧化剂抗坏血酸,以及酶促自由基清除剂超氧化物歧化酶和过氧化氢酶均可减少α-HBDH的释放。本研究证实了以下假设,即异丙肾上腺素的氧化产物,尤其是氧和/或氧衍生自由基的形成,是长时间暴露于异丙肾上腺素后观察到的细胞毒性的原因。与异丙肾上腺素不同,暴露于5×10⁻⁴M非诺特罗(另一种不会被氧化的β-肾上腺素能激动剂)不会损害心肌细胞的活力。此外,β受体阻滞剂普萘洛尔(10⁻⁴M,10⁻⁵M)与5×10⁻⁴M异丙肾上腺素联合应用不能阻止α-HBDH的释放。这些发现表明,异丙肾上腺素诱导的心脏毒性不是过度β肾上腺素能受体激活的结果,而是由自由基的形成介导的。